In Wake of New Legislation, Right to Try Laws Remain Controversial

The new Right to Try legislation comes as a culmination of a movement that has resulted in similar laws in 40 states. However, the new law has drawn fire from a variety of healthcare stakeholders who worry about the consequences of bypassing current FDA protocols — potential harm to patients and increased liability

Pharmacy Benefit Managers Targeted by Gottlieb

Pharmacy benefits managers (PBMs), private firms that contract with health insurers to process and administer claims, are an integral part of the current pharmaceutical administration process. However, some of the current practices of PBMs have drawn significant criticism.